445 related articles for article (PubMed ID: 4214173)
1. [Blood sugar, serum insulin, nonesterified fatty acids and somatotropin in daily profile in adult diabetics under monotherapy with various sulfonylureas].
Happ J; Beyer J; Nest E; Fröhlich A; Althoff PH; Schöffling K
Arzneimittelforschung; 1974 Aug; 24(8):1228-34. PubMed ID: 4214173
[No Abstract] [Full Text] [Related]
2. Glucose, FFA, IRI and GH response to I.V. glibenclamide.
Rastogi GK; Dash RJ; Sinha MK
Horm Metab Res; 1973 Jul; 5(4):303. PubMed ID: 4199903
[No Abstract] [Full Text] [Related]
3. Circadian variations of carbohydrate tolerance in maturity onset diabetics treated with sulfonylureas.
Göschke H; Denes A; Girard J; Collard F; Berger W
Horm Metab Res; 1974 Sep; 6(5):386-91. PubMed ID: 4417576
[No Abstract] [Full Text] [Related]
4. Experience with glibenclamide.
Rastogi GK; Dash RJ; Sinha SM
J Indian Med Assoc; 1973 Jul; 61(1):60-2. PubMed ID: 4202387
[No Abstract] [Full Text] [Related]
5. [Effect of adrenergic beta-blockade using trimepranol on glucose, insulin, somatotropin and nonesterified fatty acids in the blood of women with diabetes mellitus].
Felt V; Nedvídkrová J; Hortová O
Vnitr Lek; 1974 Nov; 20(11):1050-4. PubMed ID: 4155166
[No Abstract] [Full Text] [Related]
6. [Behavior of free fatty acids in the serum following tolbutamide administration in normal persons, dietetically regulated and insulin-dependent diabetics of differing body weight and differing initial blood sugar levels].
Ulrich E; Frank I; Kujat G; Müller G; Seige K
Endokrinologie; 1969; 54(5):442-52. PubMed ID: 5359974
[No Abstract] [Full Text] [Related]
7. A clinical study of the metabolic effect of a new oral hypoglycemic agent: glipizide.
Iacono G; Ghionni A; Colucci M; Verde G; Caputo G
Int J Clin Pharmacol; 1974 Apr; 7(3):225-31. PubMed ID: 4850166
[No Abstract] [Full Text] [Related]
8. [Insulin, glucose and free fatty acids in the serum of healthy and diabetic subjects following solitary oral dose of the sulfonylurea derivative glibornuride].
Herrlinger H; Dörfler H; Wolfram G; Zöllner N
Verh Dtsch Ges Inn Med; 1971; 77():550-2. PubMed ID: 5155895
[No Abstract] [Full Text] [Related]
9. Proceedings: Half-life of phenprocoumarol (Marcumar R) during treatment with insulin and sulfonylureas in diabetics.
Heine P; Kewitz H; Wiegboldt KA
Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R30. PubMed ID: 4276557
[No Abstract] [Full Text] [Related]
10. Response of plasma insulin, serum free fatty acids and blood glucose in growth onset diabetics, to I.V. tolbutamide.
Kirti S; Dutta PK; Vaishnava H; Singh RB
J Assoc Physicians India; 1976 Mar; 24(3):141-6. PubMed ID: 1010812
[No Abstract] [Full Text] [Related]
11. [Mechanism of action of gliquidone (author's transl)].
Zilker T; Ermler R; Henderkott U; Bottermann P
Dtsch Med Wochenschr; 1975 Aug; 100(35):1733-4, 1739-41. PubMed ID: 808405
[TBL] [Abstract][Full Text] [Related]
12. [Mechanism of the antidiabetic action of sulfanylurea derivatives].
Iaroshevskiĭ IuA; Volkova EA
Klin Med (Mosk); 1982 Oct; 60(10):94-7. PubMed ID: 6757562
[No Abstract] [Full Text] [Related]
13. Comparative effects of two doses of glibenclamide upon metabolic rhythms in maturity-onset diabetics.
Nattrass M; Hinks L; Smythe P; Todd PG; Alberti KG
Diabete Metab; 1978 Sep; 4(3):175-80. PubMed ID: 101402
[TBL] [Abstract][Full Text] [Related]
14. [Glisoxepide treatment in maturity-onset diabetics (author's transl)].
Happ J; Beyer J; Ulreich F; Schöffling K; Krause U; Frönlich A
Dtsch Med Wochenschr; 1976 Nov; 101(45):1643-6. PubMed ID: 1033056
[TBL] [Abstract][Full Text] [Related]
15. [Therapy of diabetes in adults using Glibornurid. Results and clinical studies].
Schöffling K; Mehnert H; Ewald W; Haupt E; Wicklmayr M; Beyer J; Nemeth N
Dtsch Med Wochenschr; 1973 May; 98(18):915-9. PubMed ID: 4633717
[No Abstract] [Full Text] [Related]
16. [Clinical testing of a sulphonylurea derivative, glibornuride].
Zöllner N; Dörfler H; Wolfram G
Dtsch Med Wochenschr; 1972 Jul; 97(29):1083-8. PubMed ID: 4625427
[No Abstract] [Full Text] [Related]
17. [Oral antidiabetic therapy with delayed-action glibenclamide and phenformin in fixed combination].
Beringer A
Minerva Med; 1974 Sep; 65(60):3127-39. PubMed ID: 4214043
[No Abstract] [Full Text] [Related]
18. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
Loubatiéres A; Mariani MM; Ribes G; Alric R
Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675
[No Abstract] [Full Text] [Related]
19. [Body weight and form of therapy in the course of diabetes mellitus].
Lohmann D; Koll P
Dtsch Z Verdau Stoffwechselkr; 1973; 33(1):1-9. PubMed ID: 4773209
[No Abstract] [Full Text] [Related]
20. [Changes in insulin (IRI) and NEFA levels in diabetic subjects after acute intravenous glipizide and tolbutamide administration].
Fedeli S; Maglia A
Arch Sci Med (Torino); 1977; 134(1):33-8. PubMed ID: 860916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
